SCHEMBL16465787

SCHEMBL16465787

O=C1NCCC1Oc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 5/20 0.54
CRBN Q96SW2 5/20 0.54
ALDH1A1 P00352 1/20 0.43
HRH1 P35367 1/20 0.42
NISCH Q9Y2I1 1/20 0.40
LTA4H P09960 5/20 0.39
TSHR P16473 1/20 0.39
GSTP1 P09211 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
AKR1B1 P15121 1/20 0.38
HPGD P15428 1/20 0.38
KCNH2 Q12809 1/20 0.38
SCN3A Q9NY46 1/20 0.38
HCK P08631 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15633784 1.00 DDB1 (0.54) DDB1CRBNALDH1A1HRH1NISCH
SCHEMBL16148496 0.93 DDB1 (0.60) DDB1CRBNHRH1
SCHEMBL15633085 0.86 FPR2 (0.42) DDB1CRBNLTA4HKCNH2
SCHEMBL15633084 0.86 FPR2 (0.42) DDB1CRBNLTA4HKCNH2
SCHEMBL15633110 0.81 MAOB (0.47) DDB1CRBNGSTP1MAOAMAOB
SCHEMBL15633111 0.81 MAOB (0.47) DDB1CRBNGSTP1MAOAMAOB
SCHEMBL20613502 0.80 DDB1 (0.41) DDB1CRBNHRH1
SCHEMBL19297511 0.80 DDB1 (0.41) DDB1CRBNMAOAMAOB
SCHEMBL4789557 0.80 SLC6A4 (0.44) DDB1CRBN
SCHEMBL15632987 0.80 DDB1 (0.41) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2906550-B1 PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS SANOFI SA (FR) 2016-08-24 EP disclosed
EP-2906550-A1 PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS SANOFI (FR) 2015-08-19 EP disclosed
WO-2014056938-A1 PYRROLIDINONE DERIVATIVES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS SANOFI (FR) 2014-04-17 WO disclosed